XLS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Xlife Sciences AG

Watchlist Manager

Watchlist

Price: 14.1 EUR -15.57% Market Closed

Market Cap: €81.4m

	Xlife Sciences AG F:XLS	CH
	Outbrain Inc NASDAQ:OB	US
T	TDSPharm Co Ltd KOSDAQ:464280	KR
	Country-Wide Insurance Co OTC:CWID	US
	Mersen SA F:CBE	FR
V	Voyager Therapeutics Inc F:VT6	US
	Capella Minerals Ltd F:N7D	CA
	Psyched Wellness Ltd OTC:PSYCF	CA

Profitability Summary

Xlife Sciences AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

62%

Strong 3Y Average Gross Margin

57%

Gross Margin is Increasing

30% > 62%

Negative Operating Margin

-2 318%

Negative 3Y Average Operating Margin

-2 142%

Declining Operating Margin

-2 141% > -2 318%

Exceptional Net Margin

3 664%

Strong 3Y Average Net Margin

2 855%

Net Margin is Increasing

1 607% > 3 664%

Negative Free Cash Flow Margin

-27%

Strong 3Y Average Free Cash Flow Margin

32%

Free Cash Flow Margin is Increasing

Negative 3Y Average ROIC

-6%

ROIC is Increasing

-8% > -5%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.